Results 231 to 240 of about 9,194 (267)

Outcomes and patterns of use of Radium-223 in metastatic castration-resistant prostate cancer. [PDF]

Front Oncol
Anido-Herranz U, Fernandez-Calvo O, Ruiz-Bañobre J, Martinez-Breijo S, Fernandez-Nuñez N, Nogareda-Seoane Z, Garrido-Pumar M, Casas-Nebra J, Muñiz-Garcia G, Portela-Pereira P, Gomez-Caamaño A, Perez-Fentes DA, Santome-Couto L, Lázaro M, Molina-Diaz A, Medina-Colmenero A, Vazquez-Estevez S.   +16 more
europepmc   +1 more source

Die moderne Diagnostik und individualisierte Therapie des Prostatakarzinoms [PDF]

, 2018
Herlemann, Annika
core  

Reasons for Patients (Pts) Discontinuing Study Treatment (Tx) in the Phase 3 Alsympca Trial of Radium-223 Dichloride (Ra-223) in Castration-Resistant Prostate Cancer (Crpc) with Bone Metastases (Mets)

, 2014
John Logue, Saskia Wedel, Aleš Chodacki, Oliver Sartor, Sten Nilsson, Robert E. Coleman, Nicholas D. James, A. Aksnes, Mona Wahba, Chris Parker   +9 more
openalex   +1 more source

Alkaline phosphatase decline and pain response as predictors of overall survival benefit in patients treated with radium-223: a post hoc analysis of the REASSURE study. [PDF]

Br J Cancer
O'Sullivan JM, Heinrich D, Castro E, George S, Dizdarevic S, Baldari S, Essler M, Jong IJ, Lastoria S, Hammerer PG, Tombal B, James ND, Meltzer J, Sandström P, Sartor O.   +14 more
europepmc   +1 more source

Radium Ra 223 Dichloride Therapy in the Private Practice Environment.

, 2016
Jeffrey C. Seeber
openalex   +2 more sources

Joint Regional Uptake Quantification of Thorium-227 and Radium-223 Using a Multiple-Energy-Window Projection-Domain Quantitative SPECT Method. [PDF]

IEEE Trans Med Imaging
Li Z, Benabdallah N, Laforest R, Wahl RL, Thorek DLJ, Jha AK.   +5 more
europepmc   +1 more source

Synergistic Activity of DNA Damage Response Inhibitors in Combination with Radium-223 in Prostate Cancer. [PDF]

Cancers (Basel)
Dunne VL, Wright TC, Liberal FDCG, O'Sullivan JM, Prise KM.   +4 more
europepmc   +1 more source

Meeting Report From the Prostate Cancer Foundation Scientific Working Group on Radium‐223

, 2016
Andrea K. Miyahira, Michael J. Morris, Howard R. Soule, PCF Radium‐223 Scientific Working Group   +3 more
openalex   +2 more sources

Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer. [PDF]

Cancer Immunol Res
Choudhury AD, Kwak L, Cheung A, Allaire KM, Marquez J, Yang DD, Tripathi A, Kilar JM, Flynn M, Maynard B, Reichel R, Pace AF, Chen BK, Van Allen EM, Kilbridge K, Wei XX, McGregor BA, Pomerantz MM, Bhatt RS, Sweeney CJ, Bubley GJ, Jacene HA, Taplin ME, Huang FW, Harshman LC, Fong L.   +25 more
europepmc   +1 more source